Fiduciary Group’s GSK GSK Stock Holding History

Fiduciary Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,801	Closed	-$249K	–	273
2024 Q1	$249K	Hold	5,801	–	–	0.03%	242
2023 Q4	$215K	Sell	5,801 -3,566	-38%	-$128K	0.03%	247
2023 Q3	$340K	Hold	9,367	–	–	0.04%	192
2023 Q2	$334K	Hold	9,367	–	–	0.04%	193
2023 Q1	$333K	Buy	9,367 +300	+3%	+$10.5K	0.04%	188
2022 Q4	$319K	Sell	9,067 -320	-3%	-$10.7K	0.04%	187
2022 Q3	$314K	Buy	+9,387	New	+$356K	0.04%	189

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Fiduciary Group's GSK Position: Q2 2024 in Review

Fiduciary Group sold out of GSK (GSK) in Q2 2024, closing a stake of 5,801 shares — an estimated $249K sold.

Fiduciary Group first reported a position in GSK in Q3 2022 and held it in 7 quarters. The position peaked at $340K in Q3 2023. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

Fiduciary Group reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
Fiduciary Group sold 5,801 GSK shares in Q2 2024, an estimated $249K.
Fiduciary Group first reported a position in GSK in Q3 2022 and held it in 7 quarters.
Fiduciary Group's GSK position peaked at $340K in Q3 2023.
884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Fiduciary Group's 13F filing for Q2 2024, filed 8 Aug 2024.